logo
Plus   Neg
Share
Email

Dycom Projects Q2 Results Below Previous Guidance - Quick Facts

Dycom Industries, Inc. (DY) announced, for the quarter ended January 27, 2018, the company expects revenue of approximately $655.0 million, below the midpoint of its previous guidance. Dycom expects adjusted earnings per share ranging from $0.09 - $0.12, which is also below previous guidance. The company said widespread adverse weather reduced the number of available workdays and negatively impacted productivity and margins during the quarter ended January 27, 2018. Margins were also impacted by costs incurred in conjunction with the initiation of large customer programs.

Looking forward, the company provided financial guidance for fiscal 2019 ending January 26, 2019, and updated outlook for the quarter ending April 28, 2018 (first quarter of fiscal 2019). The company said the guidance reflects the anticipated timing of activity on large customer programs and the related impacts on margins as well as consideration of near-term weather conditions.

For the first-quarter, adjusted earnings per share are now expected to range from $0.63 to $0.78; and contract revenues are expected in the range of $720 - $750 million. For fiscal 2019, the company expects adjusted earnings per share of $5.22 - $6.14; and contract revenues of $3.30 - $3.50 billion.

Shares of Dycom were down 7% in pre-market trade on Monday.

The company plans to report full financial results for the second quarter period ended January 27, 2018 on February 28, 2018, before the open of trading on the NYSE.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug major Roche Holding AG reported Wednesday higher sales in its first nine months of fiscal 2018, with growth in Pharmaceuticals sales in all regions except Europe. Diagnostics Division also recorded higher sales in all regions. Looking ahead to fiscal 2018, Roche confirmed its outlook for higher results at constant exchange rates. Online-video streaming service Netflix Inc. (NFLX), Tuesday reported a third-quarter profit that surged from last year as revenues increased 34% driven largely by strong subscriber additions. Shares surged nearly 12 percent in the after-hours trading. Netflix added 6.96 million subscribers globally... Despite opposition from the pharmaceutical industry, President Donald Trump's administration has proposed a new rule requiring companies to include the prices for prescription drug and biological products in their television advertisements.
Follow RTT